Valeant Pharmaceuticals International Inc (NYSE:VRX)

237.53
Delayed Data
As of May 22
 +4.26 / +1.83%
Today’s Change
106.00
Today|||52-Week Range
238.49
+65.98%
Year-to-Date
Billionaire George Soros Just Sold These 3 Stocks: Should You?
May 23 / MotleyFool.com
Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog
May 18 / Zacks.com
Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog
May 22 / Zacks.com
AstraZeneca Reports Data from KODIAC studies on Movantik - Analyst Blog
May 18 / Zacks.com
Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog
May 22 / Zacks.com
Astellas' Myrbetriq for Overactive Bladder Efficient as Add-On - Analyst Blog
May 18 / Zacks.com
Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog
May 22 / Zacks.com
The Second-Strongest Stock Market Sector Doesn't Jibe With the Strongest
May 18 / TheStreet.com
Calithera Biosciences (CALA) in Focus, Stock Rises 10.8% - Tale of the Tape
May 22 / Zacks.com
Lone Pine Capital Shuffles Its Top 5 Positions
May 18 / Benzinga
Synergy Pharmaceuticals (SGYP) Jumps: Stock Rises 7.3% - Tale of the Tape
May 22 / Zacks.com
Amgen Announces Positive Results on Migraine Candidate - Analyst Blog
May 15 / Zacks.com
Alibaba, Dollar General and 3 Other Stocks Big Hedge Funds Hated Last Quarter
May 21 / TheStreet.com
Corcept Therapeutics' Korlym Positive in Breast Cancer Study - Analyst Blog
May 15 / Zacks.com
Valeant Pharmaceuticals International (VRX) Reaches New Lifetime High Today
May 21 / TheStreet.com
Heron Therapeutics' HTX-019 Meeting with FDA Successful - Analyst Blog
May 15 / Zacks.com
5 Stocks the Biggest Hedge Funds Bought Last Quarter
May 21 / TheStreet.com
GlycoMimetics' Leukemia Drug Gets Orphan Status in U.S. - Analyst Blog
May 15 / Zacks.com
6 stocks to buy...according to hedge funds
May 21 / CNNMoney.com
Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog
May 15 / Zacks.com
Should You Get Rid of Aerie Pharmaceuticals (AERI) Now? - Tale of the Tape
May 20 / Zacks.com
McKesson Beats on Q4 Earnings & Revenues, Guides Strong - Analyst Blog
May 13 / Zacks.com
Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog
May 19 / Zacks.com
Johnson & Johnson's Invega Sustenna sNDA Suffers Setback - Analyst Blog
May 12 / Zacks.com
Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog
May 19 / Zacks.com
Eli Lilly & BioNTech Collaborate for Cancer Immunotherapies - Analyst Blog
May 12 / Zacks.com
Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog
May 19 / Zacks.com
Pfizer Acquires Stake in Dutch Biopharmaceutical Company - Analyst Blog
May 12 / Zacks.com
Portfolio Manager Minyi Chen On Why Certain Companies Are Likely M&A Targets
May 18 / Benzinga
Catalyst Pharmaceutical's Q1 Loss Narrower than Expected - Analyst Blog
May 12 / Zacks.com
Endo International (ENDP) Expands Generics with $8 Billion Par Pharma Buy - Stocks i...
May 18 / Zacks.com
Novartis' Zykadia Approved in the EU for Lung Cancer - Analyst Blog
May 11 / Zacks.com
Immunomedics' Drug Gets Fast Track Status for Lung Cancer - Analyst Blog
May 18 / Zacks.com
4 stock tips from Wall Street's star managers
May 05 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account